3,349 press releases indexed under healthcare.
A matching gift of up to $5,000 per organization supports oral health care at every stage of life, from underserved children to vulnerable seniors, as part of the conference's Continuum of Care initiative. DENVER, July 15, 2026 /PRNewswire-PRWeb/ -- The Dykema DSO Industry Group today...
(PR-inside.com) LIVONIA, MI / ACCESS Newswire / July 15, 2026 / So, you're thinking about launching aRemote Patient Monitoring (RPM)program for your clinic but aren't sure where to begin? You're not alone. Many small and medium sized clinics recognize the value of RPM but are unsure how to get started or what challenges to expect. This article explores why now is the right time to adopt RPM, the common barriers that hold smaller practices back, how a modern platform simplifies implementation, and the benefits clinics and patients can experience once an RPM program is up and running. Why Small and Medium Sized Clinics Need ..
Learn how small and medium-sized clinics can launch a Remote Patient Monitoring (RPM) program with HumHealth to improve patient care and simplify billing.
LOS ANGELES, CA - July 15, 2026 ( NEWMEDIAWIRE ) - Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) was featured in a recent article that discussed its advancement of its proprietary multiple sclerosis therapy candidate, LUCID-MS, which is designed to target demyelination and protection or restoration of myelin integrity. The company reported that Phase 1 clinical studies in healthy volunteers demonstrated a favorable safety profile and that the therapy was generally well tolerated, supporting advancement into patient-focused studies. In April 2026, Quantum BioPharma submitted an Investigational New Drug application to the U.S. Food and Drug Administration for LUCID-MS, paving the way for a planned Phase 2 clinical trial in people living with multiple sclerosis. The company believes the therap
LOS ANGELES, CA - July 15, 2026 ( NEWMEDIAWIRE ) - Artificial intelligence is becoming an increasingly important component of pharmaceutical research, with companies using machine learning to analyze complex biological data, identify drug targets and improve clinical development decisions. Against that backdrop, VERAXA Biotech (NASDAQ: VRXA) , an emerging leader in designing novel cancer therapies, announced a collaboration with AI-focused research partner Ardigen that is intended to strengthen development of the company’s BiTAC(R) oncology platform through AI-enabled target discovery and validation ( https://ibn.fm/yoDH5 ). Artificial intelligence is becoming an increasingly important tool for drug discovery, with major pharmaceutical companies expanding AI collaborations across oncology
LOS ANGELES, CA - July 15, 2026 ( NEWMEDIAWIRE ) - SS Innovations International (NASDAQ: SSII) , a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors and will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system. Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO role
Cosmos Health has now repurchased a total of 4,588,000 shares for approximately $970,000.
COLORADO SPRINGS, Colo., July 15, 2026 /PRNewswire/ -- IntraNerve Neuroscience today announced the appointment of two new medical directors, strengthening the company's clinical leadership across its services lines. Margot Nagan, MD has been named Medical Director for the EEG service...
Co-founder Robin Shah continues as executive chairman, devoting his full focus to launching new business lines that build on Thyme Care's patient, provider and payer footprint, while continuing to oversee the successful core business built over the last six years. Brad Diephuis, M.D.,...
KLOW vs. GLOW is becoming the newest peptide-stack comparison patients are searching as beauty, recovery, inflammation, and compounded peptide therapy collide in the wellness conversation. GLOW is commonly discussed online as a peptide blend built around GHK-Cu, BPC-157, and TB-500. KLOW is commonly described as a similar blend with KPV added, shifting the conversation toward inflammation, gut-skin signaling, and deeper recovery-focused interest. California Trim Clinic says the trend reflects a larger shift in patient demand. People are no longer asking only about weight loss. They are asking about skin quality, recovery, body composition, healthy aging, inflammation, and what doctor-guided compounded peptide care may look like. The post KLOW or GLOW? California Trim Clinic breaks down the
With sports dominating current global headlines, players of all backgrounds are feeling energized, fighting for their spot on the field and taking steps to boost their own power. However, a key aspect of training is also proper recovery support, a need industry leader BlackLabel Supplements is meeting through the release of their new Recovery Protein formula to ensure consistent energy restoration. The post BlackLabel Supplementsâ¢, Leader in High-Quality Sports Formulations, Unveils New 'Recovery Protein' first appeared on
Independent review confirms DNV's hospital standards continue to meet international healthcare accreditation principles. HOUSTON, July 15, 2026 /PRNewswire/ -- DNV has announced that its International Accreditation Standards for Hospitals (DIAS), Revision 26-0, has received renewed...